Literature DB >> 23375966

Intravenous immunoglobulin for Alzheimer's disease.

Clive Holmes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23375966     DOI： 10.1016/S1474-4422(13)70015-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

Review 1.  The demand for polyvalent immunoglobulins in Italy.

Authors:  Fabio Candura; Monica Lanzoni; Gabriele Calizzani; Samantha Profili; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 2.  Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.

Authors:  Reza Majidazar; Erfan Rezazadeh-Gavgani; Saeed Sadigh-Eteghad; Amirreza Naseri
Journal:  Eur J Clin Pharmacol       Date:  2022-07-26       Impact factor: 3.064

3.  Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's disease.

Authors:  Yu-Hui Liu; Jun Wang; Qiao-Xin Li; Christopher J Fowler; Fan Zeng; Juan Deng; Zhi-Qiang Xu; Hua-Dong Zhou; James D Doecke; Victor L Villemagne; Yen Ying Lim; Colin L Masters; Yan-Jiang Wang
Journal:  Sci Adv       Date:  2021-01-01       Impact factor: 14.136
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.